Clinical Trials Directory

Trials / Completed

CompletedNCT03778736

Using Cumulase for Denudation of Cycles With ≤ 8 Cumulus-oocytes Complexes

Can Cumulase Reduce the Shear Stress During Denudation for ICSI Cycles of ≤ 8 Cumulus-oocytes Complexes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
586 (actual)
Sponsor
Ibn Sina Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The cumulus-corona-oocyte complex (COCs) surrounds each oocyte and must be removed prior to intracytoplasmic sperm injection (ICSI). This is traditionally achieved with a bovine-derived hyaluronidase followed by mechanical denudation through pipetting. A human recombinant hyaluronidase (Cumulase) has been developed to circumvent the problems and concerns associated with the animal origin and lack of purity of the bovine-derived form of the enzyme. whether cumulase offers a higher chance for success after ICSI for women with 8 COCs or lower remains an open question.

Conditions

Interventions

TypeNameDescription
OTHERCumulase denudationTesting the effect of cumulase for women with poor oocyte yield due to poor ovarian reserve

Timeline

Start date
2018-01-27
Primary completion
2019-08-01
Completion
2019-08-05
First posted
2018-12-19
Last updated
2019-08-07

Locations

3 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03778736. Inclusion in this directory is not an endorsement.

Using Cumulase for Denudation of Cycles With ≤ 8 Cumulus-oocytes Complexes (NCT03778736) · Clinical Trials Directory